BriaCell Therapeutics

(: BCTXF)

Symbol has changed to a new ticker symbol

(BCTXD)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp., is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with Incyte drugs, INCMGA00012, and epacadostat, in advanced breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing and is designed to produce a potent and selective immune response against the cancer of each patient eliminating the time, expense and complex manufacturing logistics associated with immunotherapies.

Contact Information

Website: www.briacell.com
Email: jwerbes@shaw.ca
Main Phone: +1 604 921-1810
Address: 235 - 15th Street
Address 2: Suite 300, West Vancouver
State: BC
City / Town: Vancouver
Country: CA
Postal Code: V7T 2X1

Issuer Information

Exchange: OTCQB
CEO: William Williams
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A